PetIQ

PetIQ, Inc. is a holding company, which engages in the manufacture, procurement, packaging, and distribution of pet health and wellness products. It operates through the Products and Services segments. The Products segment produces and distributes pet medication and health and wellness products to the retail channel. The Services segment represents all veterinary services, and related product sales provided by the firm directly to consumers. Its brands include Advecta, Betsy Farms, Delightibles, Tex Ranch, Mimis Market, and PetLock. The company was founded by McCord Christensen in 2010 and is headquartered in Eagle, ID.

Earnings data Q4 2020

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

PetIQ reports robust Q4 performance, eyes growth through acquisitions

PetIQ delivered a strong performance in Q4 2022, showcasing growth in sales, margins, and operational efficiency across its product and service segments.
While facing challenges from consumer trade-down and integration complexities, the company's strategic focus on brand portfolio expansion and service enhancements positions it for future success.
Opportunities lie in new product introductions, service expansions, and partnership growth, indicating a positive outlook for PetIQ's continued growth trajectory.
With a solid financial foundation, strategic acquisitions, and operational improvements, PetIQ is poised to capitalize on market opportunities and drive sustainable growth.

PetIQ reports record Q1 earnings, eyes growth in premium products

PetIQ delivered strong financial performance in Q1 2023, driven by robust sales growth and operational efficiency improvements.
While facing challenges in hiring veterinarians and transitioning production, the company is well-positioned for future growth.
Opportunities lie in expanding product offerings, optimizing operations, and leveraging e-commerce for sustained growth.
Overall, PetIQ remains optimistic about future performance and is on track to meet full-year expectations.

PetIQ reports record Q2 earnings, eyes growth through innovation

PetIQ delivered strong financial performance in Q2 2023, driven by robust sales growth and operational improvements across segments.
While facing challenges in managing product mix and operational efficiency, the company remains optimistic about future growth opportunities.
By focusing on customer-centric strategies, investing in innovation, and planning significant product launches, PetIQ is well-positioned for continued success.

PetIQ reports record Q3 earnings, eyes growth through operational efficiency

PetIQ's Q3 performance exceeded expectations, driven by strong sales growth in key product categories. The company's focus on operational efficiency and strategic decision-making bode well for future success. Despite challenges in certain segments, PetIQ's outlook remains positive with opportunities for continued growth and market differentiation.

PetIQ reports strong Q4 earnings, eyes growth amid market challenges

PetIQ's Q4 2023 earnings reflect robust financial performance, strategic growth initiatives, and a positive outlook for 2024, underpinned by strong brand growth and operational efficiency.
While facing challenges such as seasonal variability and market risks, PetIQ's focus on margin expansion, disciplined acquisitions, and market positioning present opportunities for sustained success and market leadership.
With a conservative approach, emphasis on pet health and wellness products, and a clear growth strategy, PetIQ is poised for continued momentum and execution in the pet care industry.

PetIQ reports record Q1 earnings, raises guidance for 2024

PetIQ's Q1 performance exceeded expectations, driven by strong sales and margin expansion. While facing challenges such as higher expenses, the company is poised for growth with raised guidance and planned marketing investments. Leveraging opportunities in key product categories and services segment expansion will be crucial for sustained success.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

PetIQ specializes in affordable veterinary services and a wide range of pet health products. The company focuses on preventive care, ensuring pet owners have convenient access to necessary treatments and medications. With integrated manufacturing and distribution capabilities, PetIQ aims to enhance pet health and wellness.

PetIQ (PETQ) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Strength Seen in PetIQ (PETQ): Can Its 7.1% Jump Turn into More Strength?

The average of price targets set by Wall Street analysts indicates a potential upside of 86.5% in PetIQ (PETQ). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Does PetIQ (PETQ) Have the Potential to Rally 87% as Wall Street Analysts Expect?

BioLife Solutions

PETQ vs. BLFS: Which Stock Is the Better Value Option?

PETQ or BLFS: Which Is the Better Value Stock Right Now?

EAGLE, Idaho, Feb. 08, 2022 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and wellness company, today announced it will report results for the fourth quarter and full year ended December 31, 2021, on Tuesday, March 1, 2022, after the market close.

PetIQ, Inc. to Report Fourth Quarter and Full Year 2021 Financial Results on Tuesday, March 1, 2022

EAGLE, Idaho, Jan. 06, 2022 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and wellness company, today announced the appointment of Kenneth Walker as an independent director on its Board of Directors, effective January 3, 2022. He will also serve on the Audit Committee of the Board. Walker has 24 years of financial experience supporting consumer, retail and e-commerce companies.

PetIQ, Inc. Announces Appointment of Financial Executive Kenneth Walker to the Board of Directors

PETQ has great potential thanks to its clinics and services segment. The plan to open up to 1,000 clinics by 2025 will reward patient shareholders with strong FCF generation in the future, as economies of scale improve margins.

PetIQ: Economies Of Scale Will Kick In Eventually

The stock price of PetIQ Inc (NASDAQ: PETQ) increased by over 6% during intraday trading today. This is why it happened.

PetIQ Stock (PETQ): Why The Price Increased Today

The shares of PetIQ Inc (NASDAQ: PETQ) have received a price target of $30 from Benchmark. These are the details.

PetIQ (PETQ) Stock: $30 Price Target From Benchmark

AdaptHealth Corp

AHCO vs. PETQ: Which Stock Is the Better Value Option?

AHCO or PETQ: Which Is the Better Value Stock Right Now?

PetIQ, Inc. (PETQ) CEO Cord Christensen on Q3 2021 Results - Earnings Call Transcript

PetIQ (PETQ) delivered earnings and revenue surprises of 0.00% and 8.02%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

PetIQ (PETQ) Matches Q3 Earnings Estimates

Reports Record Third Quarter Net Sales of $210.5 Million, an Increase of 29.9% Year-Over-Year Reports Record Third Quarter Net Sales of $210.5 Million, an Increase of 29.9% Year-Over-Year

PetIQ, Inc. Reports Record Third Quarter 2021 Financial Results

PetIQ (PETQ) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

PetIQ (PETQ) Reports Next Week: Wall Street Expects Earnings Growth

EAGLE, Idaho, Oct. 20, 2021 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and wellness company, today announced it will report results for the third quarter ended September 30, 2021, on Wednesday, November 3, 2021, after the market close.

PetIQ, Inc. to Report Third Quarter 2021 Financial Results on Wednesday, November 3, 2021

EAGLE, Idaho, Sept. 09, 2021 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and wellness company, today announced that members of the management team will present at the Jefferies Virtual Pet Care Summit on Thursday, September 16, 2021.

PetIQ, Inc. to Present at the Jefferies Virtual Pet Care Summit

Coinbase

We're far from perfect with our stock picks, as these stinkers show, but we'll gladly admit when our calls go wrong.

Barron's Worst: Coinbase, PetIQ, and 3 More Stocks That Have Done Nothing But Drop

PetIQ, Inc. (PETQ) CEO McCord Christensen on Q2 2021 Results - Earnings Call Transcript

PetIQ (PETQ) delivered earnings and revenue surprises of -10.96% and -11.32%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

PetIQ (PETQ) Q2 Earnings and Revenues Miss Estimates

EAGLE, Idaho, July 22, 2021 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and wellness company, today announced it will report results for the second quarter ended June 30, 2021, on Wednesday, August 4, 2021, after the market close.

PetIQ, Inc. to Report Second Quarter 2021 Financial Results on Wednesday, August 4, 2021

Envista Holdings Corp

NVST vs. PETQ: Which Stock Is the Better Value Option?

NVST vs. PETQ: Which Stock Should Value Investors Buy Now?

IDEXX Laboratories

Phibro Animal Health

Zoetis

Stocks like PetIQ (PETQ), IDEXX Laboratories (IDXX), Phibro Animal Health (PAHC) and Zoetis (ZTS) offering animal health products and services make great picks for long term.

Pandemic Boosts Animal Health Spending: 4 Stocks to Buy

AmerisourceBergen

Chewy

Covetrus Inc

Elanco Animal Health Inc

Freshpet

General Mills

Heska

Merck

Nestle SA

Proshares Pet Care ETF

Patterson Companies

J. M. Smucker

Unicharm Corp

Petco Health and Wellness

Zomedica

The physiological and psychological benefits that pets give us are meaningful. COVID has amplified our appreciation of this. Anticipating 6% annual growth until 2030 may be conservative, even across developed markets.

Overview Of Opportunities In Animal Companionship: A $200B Industry Growing At 6.1% Annually

EAGLE, Idaho, May 26, 2021 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and wellness company, today announced members of the management team will participate in two upcoming virtual investor conferences.

PetIQ, Inc. to Participate in Two Upcoming Virtual Investor Conferences

Boqii Holding

PetMed Express

Trupanion

While the market has taken a beating over recent days, pullbacks are the mother's milk of effective investment strategies, and shrewd market participants will already have a growing shopping list on hand. With that in mind, one area that may deserve special attention and offer outsized potential ahead is the pet care space.

Growth Stock Spotlight: Acquisition Pits CSOC as Fresh Option in Booming Petcare Market

PetIQ, Inc. (PETQ) CEO Cord Christensen on Q1 2021 Results - Earnings Call Transcript

News for PetIQ Stock (PETQ)